பிரஞ்சு சங்கம் ஆஃப் சிறுநீரகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Affluent Medical: Financial results for the -2-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Affluent Medical: Financial results for the first half of 2021 and main clinical update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
First High Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer in Connecticut
Share Article
HIFU procedure presents alternative treatment option for patients with localized prostate cancer
HIFU is ideal for the appropriate patient with localized prostate cancer who wishes to avoid radiation or prostatectomy. STAMFORD, Conn. (PRWEB) May 24, 2021 American HIFU today announced that for the first time in Connecticut high intensity focused ultrasound (HIFU), a minimally invasive procedure using ultrasound technology to treat prostate cancer, was performed by Jonathan Bernie, MD.
HIFU directs high-frequency sound waves that destroy prostate cancer tissue, with a low risk of urinary incontinence and erectile dysfunction, compared to traditional therapies. HIFU therapy for prostate cancer is indicated for men with localized prostate cancer and is an alternative to radiation or prostate removal.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored .
EDAP TMS S.A.January 14, 2021 GMT
Results on 3,329 patients demonstrate significant difference in efficacy in favor of HIFU versus Radical Prostatectomy (RP)
HIFU treatment also resulted in meaningful benefits in both urinary and erectile function versus RP showing superior quality of life preservation capability
LYON, France, January 14, 2021 EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today positive 24 month interim results from the “HIFI” study comparing outcomes from high intensity focused ultrasound (HIFU) versus radical prostatectomy (RP) in a population of prostate cancer patients. This study is sponsored by the French Association of Urology (AFU) and supported by the French Ministry of Health. The results were